Found 20 matching trials
Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai PHASE2 A study to evaluate the efficacy and safety of maralixibat in infants with ...
Show More Location
Phoenix Children's Division of Gastroenterology & Hepatology
Learn More & Join Trial
A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS) N/A An open-label, single-arm, multi-centre program providing treatment access ...
Show More Status
Approved For Marketing
Location
University of California, Los Angeles
Learn More & Join Trial
A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) N/A This study is a database study in Japan for maralixibat (TAK-625) used to t...
Show More Location
Takeda selected site
Learn More & Join Trial
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC) PHASE3 The purpose of this study is to determine if the investigational treatment ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC) PHASE3 The primary objective of this open label extension study is to evaluate the...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US) N/A The objective of this 5-year, prospective, observational cohort study is to...
Show More Location
Children's Hospital Los Angeles CHLA
Learn More & Join Trial
An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome PHASE2 This is a multicentre, extension study of LUM001 in children diagnosed with...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) PHASE3 The main aim of the study is to check if TAK-625 improves symptoms of Progr...
Show More Location
University of Tsukuba Hospital
Learn More & Join Trial
Maralixibat for Intrahepatic Cholestasis of Pregnancy PHASE2 An open label phase 2a/b trial of maralixibat in patients with Intrahepatic...
Show More Location
Birmingham Womens and Childrens NHS Foundation Trust
Learn More & Join Trial
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis PHASE2 This is an open label study in children with Progressive Familial Intrahepa...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial